 | • レポートコード：MRC2203A006 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、血液培養検査の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（機器、消耗品、その他）分析、種類別（手動型血液培養検査、自動型血液培養検査）分析、技術別（培養ベース、プロテオミクス技術、分子技術）分析、培養種類別（バクテリア、真菌、マイクロバクテリア）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の血液培養検査市場規模：製品別（機器、消耗品、その他） ・世界の血液培養検査市場規模：種類別（手動型血液培養検査、自動型血液培養検査） ・世界の血液培養検査市場規模：技術別（培養ベース、プロテオミクス技術、分子技術） ・世界の血液培養検査市場規模：培養種類別（バクテリア、真菌、マイクロバクテリア） ・世界の血液培養検査市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Becton, Dickinson and Company、Terumo Corporation、bioMerieux、…） ・市場機会・将来傾向 |
Blood Culture tests play a vital role in the diagnosis of various infectious diseases. The growing prevalence of infectious diseases coupled with advancements in diagnostic technologies is expected to boost market growth. In addition, ageing population, need for rapid analysis and treatment are projected to fuel the blood culture tests market furthermore. According to the World Health Organization, every year around 17 million people around the world die due to infectious diseases. Moreover, an increase in R&D investments and awareness in early diagnosis among the population across the globe is projected to bolster the market growth in the near future. However, the lack of skilled professionals and high cost of novel technologies expected to hinder the market growth.
Key Market Trends
Automated Blood Culture Tests Expected to Grow at Significant Rates
- Owing to the need for rapid diagnosis of the infections and other diseases the automated blood culture tests segment expected to grow at significant rates. In addition, a high adaptation of automated equipment and accuracy in the results eliminating the manual errors in results automated blood culture tests gaining traction in the market.
- According to the World Health Organization, in 2018, an estimated 10 million people were affected by tuberculosis worldwide. TB is one of the leading cause of deaths around the world. The increasing prevalence of bacterial infections especially in underdeveloped and developing countries is expected to boost the bacterial culture testing segment growth.
- The advent of the novel diagnostic technologies in culture-based tests, reduction of diagnosis time and early prevention of disease spreading expected to boost the market growth.
North America Expected to Hold Significant Share
North America region is expected to have significant market growth over the forecast period which is majorly attributed to the presence of well-established healthcare infrastructure and better access to the diagnostics. In addition, growing awareness regarding early diagnosis and treatment of infectious diseases is expected to boost market growth over the forecast period. Moreover, technological advancements in the region are majorly driving market growth. The Asia-Pacific is expected to have notable growth rate over the forecast period owing to developing healthcare infrastructure and focus of the international companies to expand into emerging countries of Asia such as China and India.
Competitive Landscape
Blood culture tests market is moderately competitive having a notable number of market players. Market players are focusing on new product launches, innovations and geographic expansions. Key market players operating in the market include Becton, Dickinson and Company, Terumo Corporation, bioMérieux, Bruker Corporation and F. Hoffmann-La Roche AG among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Incidence of Blood Infections and Ageing Population
4.2.2 Growing Demand For Rapid Diagnostics Coupled With Product Innovations
4.3 Market Restraints
4.3.1 Lack of Appropriate Reimbursement Policies
4.3.2 High Cost of Advanced Blood Culture Techniques and Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.2 Consumables
5.1.3 Others
5.2 By Type
5.2.1 Manual Blood Culture Testing
5.2.2 Automated Blood Culture Testing
5.3 By Technology
5.3.1 Culture-Based
5.3.2 Proteomic Technologies
5.3.3 Molecular Technology
5.4 By Culture Type
5.4.1 Bacterial
5.4.2 Fungal
5.4.3 Micro Bacterial
5.5 By End-User
5.5.1 Hospital Laboratories
5.5.2 Diagnostic Centers
5.5.3 Others
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle-East and Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle-East and Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Terumo Corporation
6.1.3 bioMerieux
6.1.4 Bruker Corporation
6.1.5 T2 Biosystems, Inc.
6.1.6 Abbott Laboratories
6.1.7 Luminex Corporation
6.1.8 Siemens Healthineers AG
6.1.9 F. Hoffmann-La Roche AG
6.1.10 Danaher Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS